Without a Ribbon
  • About
    • Events
    • Get In Touch
  • Rare Cancer Resources
  • Shop
  • How You Can Help
  • Meet Warriors
  • News
  • Login
  • Register

Select Page

HELP

LEARN

EVENTS

CIC-DUX4 Sarcoma

Become part of our growing rare cancer community.
Join our Facebook support group

Join Now

Posted by fatima.shakeel@opmc.co | May 28, 2026

What is CIC-DUX4 Sarcoma?

CIC-DUX4 Sarcoma is a rare and aggressive cancer that usually develops in the soft tissues of the body, especially in the arms, legs, trunk, or deep muscles. It mainly affects children and young adults, although it can occur at any age. The tumour is caused by an abnormal fusion of the CIC and DUX4 genes, which leads to uncontrolled growth of cancer cells. It is different from Ewing Sarcoma because it has different genetic features and behaves more aggressively.

Causes

The exact cause is not fully known. The disease occurs because of a genetic change inside the tumour cells where the CIC gene joins with the DUX4 gene. This abnormal fusion activates cancer growth. The condition is usually not inherited and is not linked to injury or infection.

Signs and Symptoms

Most patients develop a rapidly growing lump or swelling in the soft tissues. Pain, tenderness, weakness, difficulty moving the affected area, fatigue, and weight loss may also occur. If the cancer spreads to the lungs, patients can develop cough, chest pain, or shortness of breath.

Diagnosis

Diagnosis is confirmed through a biopsy and laboratory testing. Imaging tests such as MRI, CT scan, and PET/CT help determine the size and spread of the tumour. Under the microscope, the tumour usually shows small round or oval cells with high mitotic activity and areas of necrosis.

Immunohistochemistry often shows positivity for CD99, WT1, DUX4, and ETV4. Molecular tests such as FISH or RT-PCR are used to confirm the CIC-DUX4 gene fusion.

Treatment

Treatment mainly includes surgical removal of the tumour. Chemotherapy and radiation therapy may also be used, although this sarcoma often responds less effectively to chemotherapy compared to Ewing Sarcoma. Regular follow-up is important because the tumour has a high risk of recurrence and spread, especially to the lungs.

Prognosis

CIC-DUX4 Sarcoma is an aggressive cancer with a poorer prognosis than many other round cell sarcomas. It commonly spreads to the lungs and has a high recurrence rate. Early diagnosis and complete treatment can improve survival outcomes.


You can help us with your donation:

Without a Ribbon is a charity that works hard to aid those who suffer from rare cancers. You can help our cause in a variety of ways:

Donations — Without a Ribbon is grateful when we receive every donation. Giving to Without a Ribbon helps us to provide ongoing support, organise the annual gathering and subsidise the costs of our Warriors attending these conferences.
Sponsorship — If you wish to sponsor our charity, please contact us using this form.
Volunteering — We are always looking for volunteers to help with different aspects of running our charity. So, if you are looking for volunteer work, please feel free to contact us.

Share:

PreviousOur New Resource Page for CIC-DUX4 Sarcoma

If you need any help or advice just

Get In Touch

© Without a Ribbon 2019. All rights reserved.Powered by WEB 105 Creative

Stay up to date.

Sign up to our newsletter